Skip to main content
Premium Trial:

Request an Annual Quote

DNAnexus, Qiagen Partner to Offer Ingenuity Variant Analysis on Cloud

NEW YORK (GenomeWeb) – DNAnexus has signed an agreement with Qiagen to integrate Ingenuity Variant Analysis, Qiagen's variant interpretation solution, with its cloud-based genomics analysis platform.

The integration gives researchers cloud-based access to manually curated literature and analysis capabilities offered by Ingenuity Variant Analysis for linking biological phenotype to variants. Customers will be able to transfer variant files from the DNAnexus cloud into the Ingenuity platform automatically for annotation, interpretation, and reporting. Furthermore, researchers will be able to refer back to supporting information such as the mapped reads found in a BAM file on DNAnexus' platform, and view this data along with the variant data inside of a genome browser.

Representatives from both companies said in a statement that integrating their products enables them to offer a complete solution for analyzing raw sequence through to insights.

Also this week, DNAnexus announced a partnership with BioNano Genomics to provide access to IrysSolve, BioNano's whole-genome analysis algorithms and pipeline, on its cloud platform.


The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.